Bank of Montreal
EPRX

Bank of Montreal’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Bank of Montreal’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$276K Buy
38,250
+1,000
+3% +$8.05K ﹤0.01% 2726
2025
Q4 		$280K Hold
37,250
– – ﹤0.01% 2636
2025
Q3 		$219K Hold
37,250
– – ﹤0.01% 2721
2025
Q2 		$215K Sell
37,250
-15,000
-29% -$57.6K ﹤0.01% 2774
2025
Q1 		$171K Sell
52,250
-4,500
-8% -$15.5K ﹤0.01% 2776
2024
Q4 		$178K Buy
56,750
+7,500
+15% +$22.2K ﹤0.01% 2801
2024
Q3 		$126K Hold
49,250
– – ﹤0.01% 3184
2024
Q2 		$133K Buy
+49,250
New +$137K ﹤0.01% 3161

Other funds holding EPRX

BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Bank of Montreal's EPRX Position: Q1 2026 in Review

Bank of Montreal increased its Eupraxia Pharmaceuticals (EPRX) stake by 2.7% in Q1 2026, buying an estimated $8.05K and bringing the position to 38,250 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #2726.

Bank of Montreal first reported a position in EPRX in Q2 2024 and has held it in 8 quarters since. The position peaked at $280K in Q4 2025. 54 funds tracked by Wall St. Rank hold EPRX as of Q1 2026.

  • Bank of Montreal held 38,250 shares of Eupraxia Pharmaceuticals worth $276K as of Q1 2026.
  • Bank of Montreal bought 1,000 Eupraxia Pharmaceuticals shares in Q1 2026, an estimated $8.05K.
  • Eupraxia Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2726 holding.
  • Bank of Montreal first reported a position in Eupraxia Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • Bank of Montreal's Eupraxia Pharmaceuticals position peaked at $280K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.